Marketresearchnews

Thursday, 22 October 2020

Cerebrospinal Fluid Management Devices Market: Information, Analytical Insights and growth of 2020 – 2027

Cerebrospinal Fluid Management Devices Market Analysis

The Cerebrospinal Fluid Management (CSF) Devices market is growing pervasively. The market growth attributes to the rising prevalence of various neurological diseases and disorders. CSF devices are primarily used in the treatment of hydrocephalus, a condition that refers to the accumulation of cerebrospinal fluid (CSF) in the brain. Hence, the growing awareness for this condition is also a significant factor that, along with the adoption of advanced and minimally invasive treatment procedures, escalates the market growth to furthered height.

According to Market Research Future (MRFR), the global cerebrospinal fluid management (CSF) devices market is estimated to grow at approx. 4.5% CAGR during the forecast period (2018 -2023). Also, factors such as the growing geriatric population and awareness about hydrocephalus propel the growth of the market. Simultaneously, the increasing prevalence of hydrocephalus in children boosts the market growth to an extent. Also, several risk factors leading to neurological disorders are creating enormous market demand.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7196

Additionally, increasing government funding and programs to support the R&D activities required for the development of CSF devices substantiate market growth. Furthermore, technological advances in the field of smart and connected devices, alongside the uses of some ubiquitous technologies such as Artificial Intelligence (AI) and the Internet of Things (IoT) to better diagnostic and treatment methods foster the market growth.

Conversely, factors such as the lack of trained professionals and side-effects associated with the treatment are projected to obstruct the market growth in years to come. Also, the high cost of CSF devices and lack of awareness for Hydrocephalus condition, act as major growth impeders for the market growth, especially in underdeveloped regions. Nevertheless, product launches of cost-competitive CSF devices would support the market growth throughout the anticipated period, filling the demand-supply gap.

Global CSF Devices Market- Segments

The report is segmented into four dynamics;

By Product: Shunts (Ventriculoperitoneal (VP), Ventriculoatrial (VA), Lumboperitoneal (LP), Ventriculopleural (VPL), others), Valve (Fixed and Adjustable), External Drainage Systems (External Ventricular Drainage (EVD) Systems, Lumbar Drainage (LD) Systems, others), and others.

By Age Group: Pediatric, Adult, and Geriatric.

By End User: Hospitals, Ambulatory Settings, Clinics, Research & Academic Institutes, and others.

By Regions: Americas, Europe, Asia Pacific, and Rest-of-the-World.

Cerebrospinal Fluid Management Devices Market - Regional Analysis

North America dominates the global cerebrospinal fluid management devices market. The largest market share attributes to the strong presence of notable market players and a large base of patients suffering from various neurological diseases & disorders. Besides, the early uptake of technologically advanced medical devices for the treatment of the growing prevalence of neurological disorders in children and adults drive the regional market growth.

Furthermore, factors such as the increasing R&D support by the governments and high expenditures in neurological care substantiate the market growth. The North American CSF devices market is estimated to retain its dominance over the global market throughout the forecast period.

Europe stands second in the global cerebrospinal fluid management devices market. Growth is driven by rising research and development investments and increasing technological advancements. Moreover, factors such as the increasing incidents of neurological disorders and focus on the development of advent diagnostic devices contribute to the regional market growth. Also, rising government support for R&D activities, alongside the increasing numbers of specialty services offered by various healthcare providers in the region fosters market growth.

Asia Pacific is an emerging market for cerebrospinal fluid management devices. Factors such as increased healthcare expenditures and rising cases of hydrocephalus drive the growth of the regional market. Additionally, growing occurrences of neurological disorders in the region, fuel the market growth. Furthermore, augmenting demand for quality devices to treat neurological diseases & disorders and penetration of healthcare technology provide impetus to the regional market growth, leading to increasing the uptake of CSF devices.

Global Cerebrospinal Fluid Management Devices Market- Competitive Analysis

Highly competitive, the CSF devices market appears fragmented, with a large number of players in the market churning the competition. Increasing incidences of drug resistance have opened doors for new entrants and leaders' development of new devices and opportunities. The rise of spurious and counterfeit devices has reduced the total market revenues, displacing standard devices off the market.

Cerebrospinal Fluid Management Devices Market Major Players:

Players leading the CSF devices market include Integra LifeSciences Holdings Corporation, Medtronic plc, B. Braun Melsungen AG, Spiegelberg GmbH & Co. KG, DePuy Synthes, SOPHYSA, Dispomedica GmbH, Natus Medical Incorporated, Delta Surgical Limited, Moller Medical GmbH, Argi Grup, G. SURGIWEAR LTD., BeckerSmith Medical, Inc., and Wellong Instruments Co., Ltd., among others.

Cerebrospinal Fluid Management Devices Industry/Innovations/Related News:

May 15, 2020 ---- Aesculap, Inc. (Germany), a leading medical device manufacturer, and its partner The Christoph Miethke GmbH & Co. KG (MIETHKE - Germany), launched the M.blue valve, the latest generation of Hydrocephalus valve technology in the US. The unique gravitational technology is integrated with a fixed differential pressure unit in one valve, allowing for a simple, position-dependent solution.

Aesculap, Inc. is a B. Braun company, the world's largest manufacturers of surgical instruments, medical devices, and sterilization container systems. The MIETHKE develops, produces, and distributes innovative neurosurgical products for the treatment of hydrocephalus. The partnership demonstrates an impactful collaborative effort to bring better Hydrocephalus solutions to patients, such as the new M.blue valve.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cerebrospinal-fluid-management-devices-market-7196

Global Healthcare Asset Management Market to Significant Growth Foreseen by 2023

Healthcare Asset Management Market Overview

Healthcare asset management uses technologies such as Radiofrequency Identification (RFID) and plays a significant role in making efficient use of medical equipment, maintaining inventories, and minimizing human error. The hospital asset management system helps monitor and secure hospital facilities and uses automated software systems to track the environment on the hospital campus.

As per Market Research Future (MRFR) analysis, the healthcare asset management market is projected to grow at a CAGR of 18.2% from 2018 to 2023 (forecast period). The report on healthcare asset management is a comprehensive analysis and overview of drivers, restraints, opportunities, market trends, market size, forecasts, and developments in the healthcare asset management market.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6335

Healthcare Asset Management Market Dynamics

The increasing concern for patient safety, the need to make available resources more effective, and the adoption of advanced technology in the healthcare sector is expected to drive the healthcare asset management market growth. In addition, increasing investment in R&D and strategies adopted by major players such as the production of new products are contributing to market growth. For example, in August 2018, the latest version of Enterprise Asset Management (EAM) software was announced by Infor Inc., which is a major player in the healthcare asset management market.

Increasing concerns about patient safety, system accuracy problems, high deployment costs for healthcare asset management devices, and poor implementation due to organizational and infrastructure issues can impede market growth during the assessment period.

Healthcare Asset Management Market Key Players

Some of the key players in the healthcare asset management market are

cenTrak
Airista Flow
GE Healthcare
IBM Corporation
Infor Inc.
Tyco Security Products.
Intelligent InSites
Motorola Solutions Inc.
Radianse
JADAK (a Novanta Company)
Siemens Healthineers
Sonitor Technologies
Stanley Black & Decker Inc.
Ekahau Inc.

Healthcare Asset Management Market Segmentation

The healthcare asset management market has been segmented on the basis of product, application, end-user, and region.

Based on the product, the market has been categorized as Real-Time Location Systems (RTLS), Radio Frequency Identification (RFID) devices and Ultrasound & Infrared Tags. The real-time location systems (RTLS) section was further divided into hardware, software, and services. The hardware section was further divided into tags/badges, and readers/interrogators.

Radio frequency identification (RFID) systems have been categorized as hardware, software, and services. The hardware section was divided into tags, readers/interrogators, and accessories. Sub-segment tags have been segmented into passive tags, and active tags. The passive tag section was slit into high-frequency (HF) tags, ultra-high-frequency (UHF) tags, and low-frequency (LF) tags. In addition, the application category has been sub-segmented in hospital asset management and pharmaceutical asset management. The hospital asset management section covers equipment monitoring and management, patient management, temperature and humidity monitoring, personnel management and prevention of diseases, and compliance with hand hygiene. The section of pharmaceutical asset management covers anti-counterfeiting drugs and supply chain management.

Based on end-user, the market has been segmented into Hospital/Clinic, Laboratories, Pharmaceutical companies, and Biotechnology.

Healthcare Asset Management Market Regional Analysis

Based on the region, the healthcare asset management market has been segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas are expected to dominate the healthcare asset management market due to the introduction of technologically advanced technologies, rising demand for innovative technology to combat counterfeit drugs and the existence of a well-established healthcare system, and the presence of a large network of health service providers. According to the American Hospital Association, there were 5,534 registered hospitals in the US in 2016, about 2,000 hospitals were in rural areas and more than 3,000 hospitals were located in urban areas.

The second-largest market for controlling healthcare assets is projected to be the European market. Business growth in this area can be attributed to government funding and support for the healthcare sector, combined with increased research and development. In addition, growing cases of product counterfeiting are responsible for increasing demand for healthcare asset management services and are therefore contributing to the growth of the market in the region. According to the European Intellectual Property Office, counterfeit drugs are a major concern in the healthcare sector. Revenue of USD 11,5 billion is lost annually as a result of counterfeit drugs and 10% of all globally supplied medicines are forged.

The Asia Pacific is projected to be the fastest-growing healthcare asset management market in the forecast period due to rising demand for easy-to-use asset management tools, rising digitalization in the region, and investment in healthcare and development by market players in the region.

The market in the Middle East and Africa is projected to account for the lowest share of the healthcare asset management market due to the underdeveloped healthcare system, inadequate medical services, and lack of professional expertise.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-asset-management-market-6335

About Market Research Future:

Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Radiology Services Market Research Report 2020 Analysis and Forecast to 2024

Market Highlights

The Global Radiology Services Market is accounted for USD 8,102.51 million in 2018 and expected to register 10.5% CAGR during the forecast period (2019–2024).

The radiology services refer to an expert consultant treating disease by choosing the proper examination, interpreting the resulting medical images, and using test results in monitoring the operations of medical care, treating diseases by using radiation or minimally invasive, image-guided therapeutic arbitration.

Browse Sample of the Report @ https://www.marketresearchfuture.com/reports/radiology-services-market-7904

The increasing healthcare expenditure, prevalence of the chronic disease, technology advancement, the emergence of thin client 3D viewers, increasing demand for minimally invasive procedures are the factor driving the growth of the market. Moreover, rising spending on research and development and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, according to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes will be the 7th leading cause of death by 2030. Also, 80% of diabetes patients live in less developed regions in the world. Increasing cases of obesity, socioeconomic transitions, and nutrition transitions are promoting the occurrence of diabetes, especially in low & middle-income countries, such as Brazil, Russia, India, China, and South Africa. Therefore, the rising prevalence of diabetes is supporting market growth.

However, high radiation exposure associated with the devices may hinder the growth of the market during the assessment period.

Segmentation

The global radiology services market has been segmented on the basis of product type, application, technology, end user, and region.

On the basis of the product type, the market has been segmented into stationary digital radiology systems and portable digital radiology systems. stationary digital radiology systems have been further segmented into stationary ceiling-mounted systems and floor-to-ceiling mounted system. On the basis of the application, the market has been classified into cardiovascular imaging, chest imaging, dental imaging, mammography imaging, orthopedic imaging, and others. Based on the technology, the market has been segmented into computed radiology and direct digital radiology. On the basis of the end user, the market has been classified as hospitals, diagnostic centers, and others. The stationary digital radiology segment is likely to hold the noticeable market share of the radiology services market due to the rising demand for stationary systems in hospitals, wide application, and less radiation exposure. However, portable digital radiology segment is showing the highest growth rate during the assessment period owing to simplicity in workflow, low-cost, and proficiency performing complex computational tasks.

Key Players

Some of the prominent key players in the global radiology services market are 4ways Healthcare Limited, Cybernet Medical Corporation, Everlight Radiology, Global Diagnostics, Medica Reporting Ltd., Onrad, Inc, Radisphere National Radiology Group Inc., RamSoft Inc., Siemens Healthcare, Telediagnostics Services Pvt. Ltd., Telemedicine Clinic, Teleradiology Solutions Inc, and Virtual Radiology (vRAD).

Regional Analysis

The market is likely to dominate by Americas during the forecast period owing to the increasing aging population, chronic disease, funding & investments, and government initiative towards advance healthcare infrastructure. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with increasing research and development, and favorable reimbursement policies. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing prevalence of cancer, rising investments in healthcare, and expansions by market players in the region. The market in the Middle East & Africa is likely to account for the smallest share of the global radiology services market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/radiology-services-market-7904

About Market Research Future:

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Biopreservation Market to Observe Strong Development by 2023

Recently MRFR, a leading market research firm collated a novel report on “Global Biopreservation Market Research Study” that gives comprehensive market overview about the current market dynamics with a focus on the worldwide market.

Market Research Future Published a Report named as “Global Biopreservation Market Research Report – Forecast Up To 2023”. Report provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

Segments for Global Biopreservation Market

The global biopreservation market has been segmented on the basis of product, biospecimen, and application.

Also Read : https://www.medgadget.com/2018/12/biopreservation-market-reveals-latest-trends-demand-size-share-new-updates-business-opportunities-and-challenges-with-industry-vision-to-2023.html

On the basis of product, the market has been classified as media and equipment. The media subsegment has been further divided into nutrient media, sera, and growth factors and supplements. The equipment segment has been further divided into temperature control systems, accessories, alarms & monitoring systems, incubators, centrifuges, and other equipment. The temperature control systems segment has been further classified as freezers, cryogenic storage systems, thawing equipment, and refrigerators. The biospecimen segment has been divided into human tissue samples, organs, stem cells, and other biospecimens.

The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.

Biopreservation Market – Overview

The Global Biopreservation Market is expected to grow during the forecast period (2018–2023) at a CAGR ~11.2%.

Biopreservation plays an important role in healthcare and food industry. It helps to preserve the biological product or material. It uses natural flora of biological material or the products of natural flora to preserve the product. The increasing expenditure on healthcare, a growing number of in vitro fertilization (IVF) centers, increasing awareness about stem cell and its applications are the major factors driving the growth of the global biopreservation market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as mergers and acquisitions are contributing to the growth of the market. For instance, in March 2016, Shanghai Genext Medical Technology Co Ltd announced the acquisition of a US-based Lifeline Scientific for USD 87.8 million this acquisition will help Shanghai Genext Medical Technology to enter into the clinical transplant business.

The high cost associated with biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.

Key Players for Global Biopreservation Market

Market Research Future (MRFR) recognizes the following companies as the key players in Biopreservation Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of the key players in the global biopreservation market are Thermo Fisher Scientific, Inc, VWR International, LLC., CUSTOM BIOGENIC SYSTEMS., BioLifeSolutions Inc., BioCision, Sigma-Aldrich Co., QIAGEN, Lifeline Scientific, Cesca Therapeutics Inc., Core Dynamics, Ltd., Princeton CryoTech, Biomatrica, Inc., Panasonic Biomedical, Inc., Chart Industries, and ATLANTA BIOLOGICALS

Regional Analysis for Global Biopreservation Market

The Americas are likely to dominate the global biopreservation market owing to the adoption of advanced technology, increasing spending on healthcare R&D, the presence of a well-established healthcare system, and increasing in-house sample storage in hospitals and research institutes. Moreover, presence and recent merger and acquisition activities by market players in the region are contributing to the growth of the market. For instance, in 2017, Cesca Therapeutics Inc. has acquired Sacramento’s SynGen Inc. for USD 1 million with this acquisition company has managed to add cell separation and cord blood processing products in their portfolio.

The European market is expected to be the second-largest biopreservation market. The market growth in this region can be attributed to the increasing number of births and with-it continuous increase in demand for umbilical cord preservation. According to the European Commission, in the year 2016 more than 5.1 million babies were born in Europe. Moreover, a growing number of sperm and egg banks is contributing to the growth of the market in this region.

Asia-Pacific is expected to be the fastest-growing biopreservation market during the forecast period owing to the increasing population in the region, increasing awareness about stem cell preservation and continuous development in the healthcare sector due to government funding.

The market in the Middle East & Africa is expected to account for the smallest share of the global biopreservation market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/biopreservation-market-6407

About Market Research Future:

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hemodynamic Monitoring Systems Market: Detailed Segmentation and Forecast 2023

Hemodynamic Monitoring Systems Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Increasing Incidence of Heart-Related Diseases to Positively Impact Hemodynamic Monitoring Systems Market Growth

Hemodynamic monitoring systems measure blood pressure directly from inside the arteries, heart, and veins. They also help to measure blood flow along with the oxygen content in the blood. Moreover, these systems possess interfaces that help to document electrophysiology (EP), peripheral, coronary, and diagnostic catheterizations.

Hemodynamic Monitoring Systems Market Size is anticipated to touch USD 1,054 million at a 7.3% CAGR between 2017-2023, states the latest Market Research Future (MRFR) report.

Also Read : https://www.medgadget.com/2019/12/hemodynamic-monitoring-systems-market-revenue-to-worth-over-usd-1054-mn-by-2023-marketresearchfuture-com.html

Various factors are propelling the hemodynamic monitoring systems market growth. Such factors, according to the latest Market Research Future report, include awareness initiatives about hemodynamic monitoring systems by industry players, favorable compensation policies, rising aging population, rising number of hospital surgeries, the introduction of favorable government schemes for creating awareness about the respiratory and cardiovascular illness, and increasing rate of cardiovascular disorders. Additional factors propelling the growth of the hemodynamic monitoring systems market include increasing incidence of heart-related diseases, especially obesity, hypertension, and diabetes that causes heart-related disorders, including heart attacks, heart failures, and cardiac arrests, and technological advancements in both minimally noninvasive and invasive methods utilized for hemodynamic monitoring.

On the contrary, scarcity of skilled healthcare experts, adverse reactions, unfavorable reimbursement policies, and strict government regulations are factors that may hinder the hemodynamic monitoring systems market growth during the forecast period.

Hemodynamic Monitoring Systems Market Key Players

Notable players profiled in the global hemodynamic monitoring systems market report include

Uscom,
NI Medical,
CNSystems,
CareTaker Medical,
Osypka Medical GmbH,
ICU Medical,
Deltex Medical Group Plc.,
Cheetah Medical,

LiDCO Group plc, PULSION Medical Systems SE, Edwards Lifesciences Corporation; Osypka Medical, Teleflex Incorporated, and Argon Medica. Key players have incorporated specific strategies to maintain their position in the market, such as regional expansion, product launch, mergers and acquisition, innovation, and others.

Industry News

September 2019- Baxter International has recently signed an agreement to acquire a leading manufacturer of non-invasive hemodynamic monitoring technologies, Cheetah Medical, to improve clinical outcomes through an established patient monitoring technology both to inform as well as guide the treatment decisions of clinicians.

Hemodynamic Monitoring Systems Market Segmentation

The Market Research Future report offers a complete segmental analysis of the hemodynamic monitoring systems market based on end use, product, and type.

By product, the hemodynamic monitoring systems market is segmented into minimally invasive, monitors, and disposables. Of these, the monitors segment will have the largest share in the market during the forecast period.

By type, the hemodynamic monitoring systems market is segmented into non-invasive, invasive, and others. Of these, the invasive segment will dominate the market during the forecast period.

By end user, the hemodynamic monitoring systems market is segmented into home care settings, ambulatory care centers, clinics, hospitals, and others. Among these, hospitals and clinics will lead the hemodynamic monitoring systems market during the forecast period.

Hemodynamic Monitoring Systems Market Regional Analysis

By region, the hemodynamic monitoring systems market report covers the latest trends and growth opportunities across Europe, North America, the Asia Pacific, and the Middle East and Africa. Of these, North America will dominate the hemodynamic monitoring systems market during the forecast period. Various factors propelling the growth of the hemodynamic monitoring systems market in the region include rapid acceptance of advanced technologies, growing healthcare sector, high per capita healthcare expenditure, rising incidence of minor/major heart issues, rising prevalence of obesity, hypertension, and low/high BP that results to heart disorders and diseases.

The hemodynamic monitoring systems market in Europe will have the second-largest share during the forecast period. Various factors propelling the growth of the hemodynamic monitoring systems market in the region include rising cardiovascular issues, favorable government initiatives, accessibility of advanced treatment facilities, and rising healthcare expenditure.

The hemodynamic monitoring systems market in the APAC region will have promising growth during the forecast period. Various factors propelling the growth of the hemodynamic monitoring systems market in the region include favorable reimbursement and insurance policies, initiatives undertaken by the government to augment the quality of healthcare, rapid adoption of advanced healthcare technology, increasing incidence of cardiac disorders, and increasing geriatric population.

The hemodynamic monitoring systems market in the MEA will have moderate growth during the forecast period. Saudi Arabia and South Africa are the major contributors in this region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hemodynamic-monitoring-systems-market-6678

About Market Research Future:

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Preclinical Imaging Market to Record an Exponential CAGR by 2023

Preclinical Imaging Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Preclinical Imaging Market Analysis

The global preclinical imaging market was valued USD 2.01 billion in 2017 and is likely to develop at a 6.3% CAGR between 2018- 2023, according to the recent Market Research Future (MRFR) report. Preclinical imaging, simply put, is a means of visualizing living animals for research purposes like drug development. Researchers use imaging modalities to observe changes at the molecular level, tissue, or organ, in animals responding to environmental or physiological changes. It has wide applications, including cardiac imaging, orthopedic, functional & anatomical neuroimaging, cancer research, infectious diseases, inflammation, cardiology, and neurology.

Also Read : https://www.medgadget.com/2020/05/covid-19-drives-preclinical-imaging-market-2020-demand-for-non-invasive-small-animal-imaging-techniques-to-positively-impact-preclinical-imaging-industry-growth.html

Various factors are adding to the global preclinical imaging market growth. These factors, as per the new MRFR report, include technological advances in molecular imaging, demand for small animal imaging techniques that are non-invasive, and the rising funds to support preclinical researches.

On the contrary, procedural and technological limitations related to standalone systems, significant operational and installation costs related to preclinical imaging modalities, and strict regulatory framework which governs preclinical researchers are factors that may limit the global preclinical imaging market growth over the forecast period.

Preclinical Imaging Market Segmentation

The MRFR report provides an inclusive segmental analysis of the global preclinical imaging market based on reagent and modality.

By modality, the global preclinical imaging market is segmented into magnetic particle imaging systems, photoacoustic imaging system, micro-CT, micro-ultrasound, micro-MRI, nuclear imaging systems, and optical imaging systems. Of these, optical imaging systems will lead the market over the forecast period.

By reagent, the global preclinical imaging market is segmented into preclinical CT contrast agents, preclinical ultrasound contrast agents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, and preclinical optical imaging reagents. Of these, preclinical optical imaging reagents will dominate the market over the forecast period.

Preclinical Imaging Market Regional Analysis

Based on the region, the global preclinical imaging market covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), & the Middle East & Africa (MEA). Of these, the Americas will lead the market over the forecast period. Factors adding market growth include the rising funds to support preclinical researches, demand for small-animal imaging techniques that are non-invasive, technological advances in molecular imaging, and the presence of well-established players. Besides, the quick adoption of new molecular imaging technologies, robust research and development infrastructure for life science researches, and rising preference for multimodality systems are also adding market growth.

The global preclinical imaging market in Europe is predicted to hold the second-largest share over the forecast period for the rising funds to support preclinical researches and efforts by the government to offer improved diagnostics services.

The global preclinical imaging market in the APAC region is predicted to grow at a high CAGR over the forecast period. Factors boosting the market growth include huge patient pool suffering from different chronic diseases, efforts for modernizing the healthcare sector, improving economic conditions, evolving regulatory scenario in different Asian countries, and increasing number of translational research activities. Besides, rising private-public investments for supporting radioisotope production and constant support by the government for biotechnology and pharmaceutical research and development are also adding market growth.

The global preclinical imaging market in the MEA will have the smallest share over the forecast period.

Preclinical Imaging Market Key Players

Eminent players profiled in the preclinical imaging market report include Trifoil Imaging (US), Aspect Imaging (Israel), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Mediso Ltd. (Hungary), Milabs B.V. (The Netherlands), Fujifilm Holdings Corporation (Japan), PerkinElmer Inc. (US), MR Solutions (UK), and Bruker Corporation (US). Industry players have incorporated strategies such as contracts, mergers, acquisitions, joint ventures and collaborations, geographic expansions, new product launches and developments, partnerships, research and development, and strategic alliances to create a niche in the market and also cater to the consumers growing needs.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/preclinical-imaging-market-7365

About Market Research Future:

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Neonatal Intensive Care Market: Detailed Segmentation and Forecast 2023

Neonatal Intensive Care Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

Global Neonatal Intensive Care Market is expected to register a CAGR ~5.5% during the forecast period of 2018–2023 with an estimated market value of 9.1 billion in 2018. Neonatal Intensive Care Market Research Report: by Product (Infant Warmers, Incubators, Respiratory Devices, Neonatal Monitoring Devices, Convertible Warmer & Incubators, Phototherapy Equipment, Catheters, Others), End User- Global Forecast Till 2023

Also Read : https://www.medgadget.com/2019/04/neonatal-intensive-care-market-2019-trends-growth-prospects-size-industry-analysis-regional-overview-and-forecast-to-2023.html

Key Players :

Market Research Future (MRFR) recognizes the following companies as the key players in Neonatal Intensive Care Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of the key players in the global neonatal intensive care market are

B. Braun Melsungen AG,
DRE Medical,
Digicare Biomedical Technology Inc.,
Henry Schein,
Jorgensen Labs,
Medtronic,
Midmark Corporation,
Patterson Companies, Inc.,
Smiths Group plc, and
Vetland Medical Sales & Services.

Neonatal Intensive Care Market – Sketch

It is estimated that the Global Neonatal Intensive Care Market is expected to register a CAGR ~5.5% during the forecast period of 2018–2023 with an estimated market value of 9.1 billion in 2017.

The global market is driven by factors such as rising prevalence of diseases in new-born children and increasing neonatal population. According to data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017.

On the other hand, the lack of awareness, high cost of equipment, and lack of skilled professionals is restraining the growth of neonatal intensive care market. For instance, according to a report published by the International Journal of Neonatal Screening in September 2018, the reports of false positive cases in neonates are increasing for various diseases.

The global neonatal intensive care market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning.

Regional Analysis :

The market in the Americas is expected to dominate the global Neonatal Intensive Care market during the forecast period. The rising prevalence of congenital disorders in new-born, increasing neonatal population and government support are driving the growth of the market in the Americas. According to a data published by the Centers for Disease Control and Prevention (CDC) in November 2018, congenital heart defects (CHDs) affect approximately 1% or about 40,000 births per year in the US.

Europe showed a considerable amount of growth in the global neonatal intensive care market. The market growth in this region is because of the presence of a well-established healthcare system and increase in insurance coverage for pets. Also, technological advancements in the industry and government support in terms of National Health Service and health insurance are expected to drive the market growth.

Asia-Pacific is estimated to be the fastest growing region in the market due to increased pet adoptions and rise in the number of animal welfare programs.

On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. According to the American Society of Hematology (ASH), it led a campaign to fight sickle cell disease in Africa in June 2018. It also urged the governments, particularly in sub-Saharan Africa, to invest in new-born intensive care units for the betterment of the neonates.

Segments :

The global neonatal intensive care market has been segmented into product, and end user. The market, based on product, has been segmented into infant warmers, incubators, respiratory devices, neonatal monitoring devices, convertible warmer & incubators, phototherapy equipment, catheters, and others. The market, by infant warmers, has been segmented into electric infant warmers, and non-electric infant warmers. The market, by neonatal monitoring devices, has been sub-segmented into cardiopulmonary monitor, blood pressure monitor, pulse oximeters, capnographs, and others. The market, by end user, has been segmented into hospitals, childcare clinics, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/neonatal-intensive-care-market-7513

About Market Research Future:

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com